Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids in Refractory Shock Post-Cardiac Arrest
NCT00676585Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2007
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Shock comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Time to Shock Reversal at 7 days. Started Oct 2007; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Shock
Beyond the preview
Go deeper on NCT00676585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676585.